BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20559705)

  • 1. Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.
    Lurie G; Terry KL; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Palmieri RT; Cramer DW; Goodman MT
    Cancer Causes Control; 2010 Oct; 21(10):1731-41. PubMed ID: 20559705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
    Nagao M; Sato Y; Yamauchi A
    PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.
    Lurie G; Wilkens LR; Thompson PJ; Carney ME; Palmieri RT; Pharoah PD; Song H; Hogdall E; Kjaer SK; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Gentry-Maharaj A; Menon U; Ramus SJ; Goodman MT;
    Int J Cancer; 2011 Feb; 128(4):936-43. PubMed ID: 20473893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
    Trabert B; Ness RB; Lo-Ciganic WH; Murphy MA; Goode EL; Poole EM; Brinton LA; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Lurie G; Kjær SK; Hogdall E; Jensen A; Cramer DW; Terry KL; Vitonis A; Bandera EV; Olson S; King MG; Chandran U; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike MC; Berchuck A; Schildkraut JM; Wentzensen N;
    J Natl Cancer Inst; 2014 Feb; 106(2):djt431. PubMed ID: 24503200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2070-7. PubMed ID: 18708400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.
    Cox DG; Buring J; Hankinson SE; Hunter DJ
    Breast Cancer Res; 2007; 9(1):R3. PubMed ID: 17214885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A₂ group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma.
    Liu F; Wei WQ; Cormier RT; Zhang ST; Qiao YL; Li XQ; Zhu ST; Zhai YC; Peng XX; Yan YX; Wu LJ; He D; He Y
    Asian Pac J Cancer Prev; 2014; 15(4):1797-802. PubMed ID: 24641411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
    Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
    Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.
    Danforth KN; Hayes RB; Rodriguez C; Yu K; Sakoda LC; Huang WY; Chen BE; Chen J; Andriole GL; Calle EE; Jacobs EJ; Chu LW; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
    Carcinogenesis; 2008 Mar; 29(3):568-72. PubMed ID: 17999989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.
    Ross J; Lockett L; Brookes D; Tabor B; Duesing K; Buckley M; Lockett T; Molloy P; Macrae F; Young G; Blanco I; Capella G; Hannan GN
    Eur J Hum Genet; 2013 Dec; 21(12):1389-95. PubMed ID: 23531863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk.
    Sasamoto N; Babic A; Vitonis AF; Titus L; Cramer DW; Trabert B; Tworoger SS; Terry KL
    Cancer Prev Res (Phila); 2021 Aug; 14(8):795-802. PubMed ID: 34244153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
    Langsenlehner U; Yazdani-Biuki B; Eder T; Renner W; Wascher TC; Paulweber B; Weitzer W; Samonigg H; Krippl P
    Clin Cancer Res; 2006 Feb; 12(4):1392-4. PubMed ID: 16489098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.
    Lo-Ciganic WH; Zgibor JC; Bunker CH; Moysich KB; Edwards RP; Ness RB
    Epidemiology; 2012 Mar; 23(2):311-9. PubMed ID: 22252409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population.
    Daraei A; Salehi R; Mohamadhashem F
    Mol Biol Rep; 2012 May; 39(5):5219-24. PubMed ID: 22173719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetic polymorphisms of PTGS2 and glioma in a Chinese population.
    Lin RP; Yao CY; Ren DX
    Genet Mol Res; 2015 Apr; 14(2):3142-8. PubMed ID: 25966079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
    Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
    Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
    PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma.
    Hoeft B; Becker N; Deeg E; Beckmann L; Nieters A
    Cancer Causes Control; 2008 Mar; 19(2):163-73. PubMed ID: 18038187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.